ClinVar Miner

Submissions for variant NM_152564.5(VPS13B):c.2075G>A (p.Arg692Gln)

gnomAD frequency: 0.00006  dbSNP: rs371500701
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000513467 SCV000226341 uncertain significance not provided 2017-01-10 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000193499 SCV000249403 uncertain significance not specified 2015-05-15 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000513467 SCV000609315 uncertain significance not provided 2017-05-31 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001047823 SCV001211805 uncertain significance Cohen syndrome 2023-12-11 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 692 of the VPS13B protein (p.Arg692Gln). This variant is present in population databases (rs371500701, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 194549). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt VPS13B protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000513467 SCV002549358 uncertain significance not provided 2022-07-14 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Ambry Genetics RCV002415747 SCV002729812 uncertain significance Inborn genetic diseases 2018-08-04 criteria provided, single submitter clinical testing The p.R692Q variant (also known as c.2075G>A), located in coding exon 14 of the VPS13B gene, results from a G to A substitution at nucleotide position 2075. The arginine at codon 692 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Natera, Inc. RCV001047823 SCV001456248 uncertain significance Cohen syndrome 2020-04-15 no assertion criteria provided clinical testing
GenomeConnect - Invitae Patient Insights Network RCV001047823 SCV001749838 not provided Cohen syndrome no assertion provided phenotyping only Variant interpreted as Uncertain significance and reported on 12-03-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.
PreventionGenetics, part of Exact Sciences RCV004742311 SCV005351145 uncertain significance VPS13B-related disorder 2024-03-05 no assertion criteria provided clinical testing The VPS13B c.2075G>A variant is predicted to result in the amino acid substitution p.Arg692Gln. This variant has been reported at a frequency of ~0.01% in individuals of European origin in a large population database and has been reported in ClinVar as uncertain (https://www.ncbi.nlm.nih.gov/clinvar). Based on these observations, the c.2075G>A variant is classified as uncertain.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.